APA (7th ed.) Citation

Ioannou, G. N., Beste, L. A., Chang, M. F., Green, P. K., Lowy, E., Tsui, J. I., . . . Berry, K. (2016). Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System. Gastroenterology (New York, N.Y. 1943), 151(3), 457-471.e5. https://doi.org/10.1053/j.gastro.2016.05.049

Chicago Style (17th ed.) Citation

Ioannou, George N., Lauren A. Beste, Michael F. Chang, Pamela K. Green, Elliott Lowy, Judith I. Tsui, Feng Su, and Kristin Berry. "Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System." Gastroenterology (New York, N.Y. 1943) 151, no. 3 (2016): 457-471.e5. https://doi.org/10.1053/j.gastro.2016.05.049.

MLA (9th ed.) Citation

Ioannou, George N., et al. "Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System." Gastroenterology (New York, N.Y. 1943), vol. 151, no. 3, 2016, pp. 457-471.e5, https://doi.org/10.1053/j.gastro.2016.05.049.